Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 ...

BUCHAREST, Romania, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced it has entered into an exclusive distribution agreement

Related Keywords

Albania ,Czech Republic ,Lithuania ,Hungary ,Kosovo ,Cyprus ,Croatia ,Bulgaria ,Latvia ,Turkey ,Romania ,Montenegro ,United States ,Poland ,Macedonia ,Estonia ,Malta ,Greece ,Bucharest ,Bucuresti ,Serbia ,Slovenia ,Czechia ,Rosalia Scampoli ,J Clin Endocrinol ,Ascendis Pharma ,Mert Zorlular ,Significant Health ,Kim Pharmaceuticals ,European Union ,Danish Company Ascendis Pharmaas Nasdaq ,Danish Company Ascendis Pharma ,North Macedonia ,Camilla Harder Hartvig ,Executive Vice President ,Chief Commercial ,Endocrinology Rare Disease ,Eastern Europe ,Er Kim Pharmaceuticals ,Height Trial ,Flight Trial ,Enlighten Trial ,Flight Trials ,Horm Res ,Clin Endocrinol ,Bone Miner ,Life Improvements Achieved ,Achondroplasia Treated ,One Year ,Press Release ,Region ,